Brief: Cohbar Inc - Preclinical Results Showing Efficacy Of A New Family Of Mitochondria Based Therapeutics In A Type 2 Diabetes Model
10/06/2019 14:11
June 10 (Reuters) - CohBar Inc CWBR.O :
* COHBAR INC - PRECLINICAL RESULTS SHOWING EFFICACY OF A NEW
FAMILY OF MITOCHONDRIA BASED THERAPEUTICS IN A TYPE 2 DIABETES
MODEL
Source text for Eikon: ID:nGNX5Lq0x4
Further company coverage: CWBR.O
((Briefs@thomsonreuters.com;))
Recent news on CohBar
See all newsBrief: CohBar, Inc. Q2 EPS USD -1.49
Brief: Morphogenesis And CohBar Announce Positive Results From Phase 1B Trial Of IFX-HU2.0 Personalized Cancer Vaccine, In Checkpoint Inhibitor Resistant Advanced Merkel Cell Carcinoma (MCC) And Cutaneous Squamous Cell Carcinoma (CSCC)
U.S. STOCKS ON THE MOVE-Galecto, Pinterest, Standard Lithium
CohBar surges on merger agreement with Morphogenesis
U.S. STOCKS ON THE MOVE-Chevron, Broadcom, Williams-Sonoma